Intestinal transit of an orally administered streptomycin-rifampicin-resistant variant of Bifidobacterium longum SBT2928: Its long-term survival and effect on the intestinal microflora and metabolism

Journal of Applied Microbiology

Volumn 90, Issue 1, 2001, Pages 43-52

  Fujiwara, S ^a   Seto, Y ^a   Kimura, A ^a   Hashiba, H ^a  

^a SNOW BRAND MILK PRODUCTS CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTICS; PHYSIOLOGY; POLYMERASE CHAIN REACTION;

BIFIDOBACTERIUM LONGUM; CLOSTRIDIUM SPP; ENTEROBACTERIACEAE; HUMAN INTESTINE; MICROFLORAE; ORAL ADMINISTRATION; PARENT STRAIN; PCR METHOD; PROBIOTICS; RANDOMLY AMPLIFIED POLYMORPHIC DNA;

METABOLISM;

BL 2928; BL 2928 SR; DNA; PROBIOTIC AGENT; RIFAMPICIN; STREPTOMYCIN SULFATE; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; BIFIDOBACTERIUM LONGUM; CLINICAL ARTICLE; CLOSTRIDIUM; CONTROLLED STUDY; ENTEROBACTERIACEAE; FECES MICROFLORA; HUMAN; INTESTINE FLORA; INTESTINE TRANSIT TIME; MOUSE; NONHUMAN; RANDOM AMPLIFIED POLYMORPHIC DNA;

ANIMALIA; BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM LONGUM; CLOSTRIDIA; CLOSTRIDIUM; ENTEROBACTERIACEAE;

EID: 0035122156     PISSN: 13645072     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2672.2001.01205.x     Document Type: Article

References (43)

1. Does yogurt enriched with Bifidobacterium longum affect colonic microbiology and fecal metabolites in healthy subjects?
2. Effect of dietary fibers on the induction of colorectal tumors and fecal β-glucuronidase activity in the rat
3. Fecal recovery in humans of viable Bifidobacterium sp. ingested in fermented milk
4. Bifidobacterial supplementation reduces the incidence of necrotizing enterocolitis in a neonatal rat model
5. Selective detection, enumeration and identification of potentially probiotic Lactobacillus and Bifidobacterium species in mixed bacterial populations
6. Development and application of an in vitro methodology to determine the transit tolerance of potentially probiotic Lactobacillus and Bifidobacterium species in the upper human gastrointestinal tract
7. Survival of lactic acid bacteria in the human stomach and adhesion to intestinal cells
8. Detection of Bifidobacterium longum in fecal samples after orogastric intubation using immunological test systems
9. The composition of the indigenous microbiota
10. Role of experimental microbial ecology in gastroenterology
11. Investigations into the metabolism and mode of action of the colon carcinogens 1,2-dimethyl-hydrazine and azoxymethane
12. Factors affecting the microecology of the gut
13. Proteinaceous factor(s) in culture supernatant fluids of bifido-bacteria which prevents the binding of enterotoxigenic Eschericia coli to gangliotetraosylceramide
14. Purification and characterization of a novel protein produced by Bifidobacterium longum SBT2928 that inhibits the binding of enterotoxigenic Escherichia coli Pb176 (CFA/II) to gangliotetraosylceramide
15. Effect of Bifidobacterium longum SBT 2928 (BL2928) on spontaneous liver tumorigenesis and intestinal metabolism in gnotobiotic C3H/He male mice
16. Probiotics in human medicine
17. Problems and prospects
18. Influence of diet and age on fecal bacterial enzymes
19. Selection of strains for probiotics use
20. Inhibition of Escherichia coli by bifidobacteria
21. The health potential of products containing bifidobacteria
22. Passage and survival of L. acidophilus in the human gastrointestinal tract
23. The fate and effects of transiting, non-pathogenic microorganisms in the human intestine
24. Potential of using lactic acid bacteria for therapy and immunomodulation in man
25. Die Faekal flora bei menschen. II. Mitteilung: Die Zuzammensetzung der Bifidobakterien-flora der vershiedenen Altersgruppen
26. Eine verbesserte methodik der darmflora von menschen und tieren
27. Effect of intestinal bacteria on incidence of liver tumors in gnotobiotic C3H/He male mice
28. Bifidobacteria and bifidogenic factors
29. Rapid determination of tryptophan, indol, and skatol in lumen fluid by HPLC
30. Effect of Bifidobacterium longum supplements on the human faecal microflora
31. Manipulation of the human gut microflora
32. Mortality of bifidobacteria in boiled yoghurt
33. Lactic acid bacteria in health and disease
34. Multiplication of orally administered Clostridium butyricum in rats
35. Effects of the fermented-milk administration on stool frequency and fecal microflora of constipated human adults
36. Effects of the fermented-milk administration on fecal microfiora and fecal excretion of demented senile patients who are habitually using a purgative
37. Intestinal glycolipids and their possible role in microbial colonization of mice
38. Impact on the composition of the faecal flora by a probiotic preparation: Preliminary data on maintenance treatment of patients with ulcerative colitis
39. Colonization resistance of the digestive tract in conventional and antibiotic-treated mice
40. Colonization resistance
41. Colon carcinogens, their metabolisms and mode of action
42. Role of intestinal anaerobic bacteria in colonization resistance